ENTX - CIK 0001638097
Entera Bio Ltd. (ENTX) reported revenue of $42.00K for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $42.00K | -76.8% |
| FY 2024 | $181.00K | - |
| FY 2023 | $0.00 | -100.0% |
| FY 2022 | $134.00K | -76.5% |
| FY 2021 | $571.00K | +56.4% |
| FY 2020 | $365.00K | - |
Entera Bio Ltd. (ENTX) reported revenue of $42.00K for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Entera Bio Ltd.'s revenue declined from $365.00K to $42.00K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.